Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma - Sampson, J H; Heimberger, A B; Archer, G E (J Clin Oncol, 2010)
, et al.